Clinical Updates on Dyslipidemia
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 34
Special Issue Editor
Interests: preventive cardiology; cardiovascular epidemiology; dyslipidemia; diabetes; subclinical atherosclerosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Dyslipidemia, especially dyslipidemia featuring elevated LDL-C, low levels of HDL-C, and elevated triglycerides with elevated levels of lipoprotein(a), is a well-established risk factor for atherosclerotic cardiovascular disease (ASCVD). Clinical trials conducted over the past four decades have established the role of LDL-C-lowering therapy in reducing the risk of ASCVD in a wide range of patient populations, with statins being the most common therapy and ezetimibe, PCSK9 inhibitors, and bempedoic acid being explored more recently. Icosapent ethyl also leads to improved ASCVD outcomes. Cardiovascular outcome trials involving the use of inclisiran, obicetrapib, or novel RNA-targeted agents to lower lipoprotein(a) levels are ongoing. However, despite international guidelines and a wide range of therapies for lowering LDL-C to reduce the risk of ASCVD, many people do not undergo lipid testing and are inadequately treated for LDL-C, which makes this an important gap in care. Further efforts are needed to address this clinical inertia if we are to improve ASCVD outcomes, particularly in our highest risk patients.
This Special Issue on dyslipidemia and cardiovascular disease will publish original research, reviews, and commentaries that aim to advance our knowledge on the mechanisms, epidemiology, and existing and newer therapeutic targets for dyslipidemia and cardiovascular disease.
Prof. Dr. Nathan Wong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dyslipidemia
- cardiovascular disease
- prevention
- treatment
- risk factors
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
